Prussian
Blue (ferric hexacyanoferrate (II)) for Treatment of Internal
Contamination with
Thallium or Radioactive Cesium
FDA approves a New Drug Application for Radiogardase, also known as Prussian
blue, to treat people exposed to radiation contamination, due to harmful
levels of cesium-137 or thallium.
Back to Top
Back to Drug Information
FDA/Center for Drug Evaluation and Research
Last Updated: October 3, 2003
Originator: OTCOM/DLIS
HTML by SJW |